Our Cancer Specialists

Welcome to MidAmerica Cancer Care (MACC)

Founded in late 2019, MidAmerica Cancer Care (MACC) is dedicated to providing exceptional oncology care with a personal touch, right in the heart of your community. Recognizing that every cancer diagnosis is unique, we focus on treating the whole patient—not just the disease. This patient-centered approach combines cutting-edge technology with compassionate care, ensuring that each treatment plan is tailored to the specific needs and circumstances of every individual we serve.

Our team consists of 4 experienced physicians and 10 highly skilled nurse practitioners, bringing together over 50 years of combined expertise in the fight against cancer. With a network spanning 10 convenient locations, MACC ensures that patients across the region have access to top-quality care. Our primary location at St. Joseph Medical Center in Kansas City, MO, serves as the central hub for this extensive network, allowing us to coordinate and deliver advanced oncology services effectively.

At MACC, we pride ourselves on creating a supportive environment where every patient is treated like family. From diagnosis to recovery, we are committed to walking with you through every step of your cancer journey. Our compassionate team is here to provide not only medical expertise but also the emotional support you deserve during this challenging time.

To find the care closest to you, explore our ‘Our Locations’ page, where you can learn more about each of our facilities and their commitment to bringing world-class cancer care to your neighborhood.

Clinical Trial Site Director – Mid America Cancer Care

Jennifer Ross serves as the Clinical Trial Site Director for MidAmerica Cancer Care, LLC (MACC), where she plays a pivotal role in overseeing the execution of Phase I-IV oncology clinical trials. These trials bring cutting-edge, innovative treatment options to patients throughout the greater Kansas City region, providing hope and improved care for individuals battling cancer.

With more than two decades of collaboration with Dr. Singh, Jennifer brings a wealth of experience in managing clinical research across both solid tumor and hematologic malignancies. Her expertise extends to fostering a highly skilled team of dedicated study coordinators and administrative staff who work tirelessly to advance oncology research. Under her leadership, the team strives to improve patient outcomes while ensuring greater diversity and inclusivity in clinical trial participation, reflecting the needs of the community.

To enhance its clinical trial operations, MACC has partnered with the American Oncology Network (AON), a collaboration that significantly bolsters its capabilities. Through this partnership, AON provides critical resources and specialized expertise, including operational support, regulatory oversight, and rigorous compliance assurance. This ensures that all trials meet the highest standards of care and safety, empowering MACC to deliver exceptional care to its patients while contributing to the future of oncology treatment.